{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T22:16:32Z","timestamp":1783203392120,"version":"3.54.6"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002332","name":"Semmelweis University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002332","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015498","name":"Innov\u00e1ci\u00f3s \u00e9s Technol\u00f3giai Miniszt\u00e9rium","doi-asserted-by":"publisher","award":["UNKP\\u201020\\u20103"],"award-info":[{"award-number":["UNKP\\u201020\\u20103"]}],"id":[{"id":"10.13039\/501100015498","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015498","name":"Innov\u00e1ci\u00f3s \u00e9s Technol\u00f3giai Miniszt\u00e9rium","doi-asserted-by":"publisher","award":["UNKP\\u201021\\u20103"],"award-info":[{"award-number":["UNKP\\u201021\\u20103"]}],"id":[{"id":"10.13039\/501100015498","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015498","name":"Innov\u00e1ci\u00f3s \u00e9s Technol\u00f3giai Miniszt\u00e9rium","doi-asserted-by":"publisher","award":["UNKP-23\\u20135"],"award-info":[{"award-number":["UNKP-23\\u20135"]}],"id":[{"id":"10.13039\/501100015498","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003827","name":"Nemzeti Kutatasi Fejlesztesi es Innovacios Hivatal","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003827","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["I3522"],"award-info":[{"award-number":["I3522"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["I4677"],"award-info":[{"award-number":["I4677"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["I3977"],"award-info":[{"award-number":["I3977"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015269","name":"Innov\u00e1ci\u00f3s \u00e9s Technol\u00f3giai Miniszt\u00e9rium","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005923","name":"International Association for the Study of Lung Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003825","name":"Hungarian Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003825","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011019","name":"Nemzeti Kutat\u00e1si Fejleszt\u00e9si \u00e9s Innov\u00e1ci\u00f3s Hivatal","doi-asserted-by":"publisher","award":["FK\\u2010143751"],"award-info":[{"award-number":["FK\\u2010143751"]}],"id":[{"id":"10.13039\/501100011019","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011019","name":"Nemzeti Kutat\u00e1si Fejleszt\u00e9si \u00e9s Innov\u00e1ci\u00f3s Hivatal","doi-asserted-by":"publisher","award":["TKP2021\\u2010EGA\\u201033"],"award-info":[{"award-number":["TKP2021\\u2010EGA\\u201033"]}],"id":[{"id":"10.13039\/501100011019","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011019","name":"Nemzeti Kutat\u00e1si Fejleszt\u00e9si \u00e9s Innov\u00e1ci\u00f3s Hivatal","doi-asserted-by":"publisher","award":["FK-147045"],"award-info":[{"award-number":["FK-147045"]}],"id":[{"id":"10.13039\/501100011019","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.lungcan.2026.109430","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:51:15Z","timestamp":1777564275000},"page":"109430","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Immune-related markers define clinically relevant prognostic subgroups in thymic epithelial tumors"],"prefix":"10.1016","volume":"217","author":[{"given":"Evelyn","family":"Megyesfalvi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivien","family":"Teglas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bence","family":"Ferencz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8109-0340","authenticated-orcid":false,"given":"Orsolya","family":"Pipek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Dorothea","family":"Pozonec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoltan","family":"Lippai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barnabas","family":"Revi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristof","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilla","family":"Horvath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Ferenczy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5585-1840","authenticated-orcid":false,"given":"David","family":"Izso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Radeczky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janos","family":"Fillinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krisztina","family":"Bogos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktoria","family":"Laszlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Schelch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Moser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7787-991X","authenticated-orcid":false,"given":"Clemens","family":"Aigner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4341-4153","authenticated-orcid":false,"given":"Balazs","family":"Hegedus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferenc","family":"Renyi-Vamos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8799-8624","authenticated-orcid":false,"given":"Balazs","family":"Dome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0385-1586","authenticated-orcid":false,"given":"Aron","family":"Ghimessy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsolt","family":"Megyesfalvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2026.109430_b0005","doi-asserted-by":"crossref","unstructured":"Tateo, V., Manuzzi, L., Parisi, C., De Giglio, A., Campana, D., Pantaleo, M.A., and Lamberti, G. (2021). An Overview on Molecular Characterization of Thymic Tumors: Old and New Targets for Clinical Advances. Pharmaceuticals (Basel) 14. 10.3390\/ph14040316.","DOI":"10.3390\/ph14040316"},{"key":"10.1016\/j.lungcan.2026.109430_b0010","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21239056","article-title":"Immunobiology of Thymic Epithelial Tumors: Implications for Immunotherapy with Immune Checkpoint Inhibitors","author":"Tateo","year":"2020","journal-title":"Int J Mol Sci 21."},{"key":"10.1016\/j.lungcan.2026.109430_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.102014","article-title":"Thymic epithelial tumors: from biology to treatment","volume":"86","author":"Conforti","year":"2020","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.lungcan.2026.109430_b0020","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jtho.2021.10.010","article-title":"The 2021 WHO Classification of Tumors of the Thymus and Mediastinum: what is New in Thymic Epithelial, Germ Cell, and Mesenchymal Tumors?","volume":"17","author":"Marx","year":"2022","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2026.109430_b0025","doi-asserted-by":"crossref","unstructured":"Chiappetta, M., Lococo, F., Pogliani, L., Sperduti, I., Tabacco, D., Bria, E., D'Argento, E., Massaccesi, M., Boldrini, L., Meacci, E., et al. (2021). Masaoka-Koga and TNM Staging System in Thymic Epithelial Tumors: Prognostic Comparison and the Role of the Number of Involved Structures. Cancers (Basel) 13. 10.3390\/cancers13215254.","DOI":"10.3390\/cancers13215254"},{"key":"10.1016\/j.lungcan.2026.109430_b0030","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/his.15097","article-title":"Thymic epithelial tumours: histopathological classification and differential diagnosis","volume":"84","author":"von der Th\u00fcsen","year":"2024","journal-title":"Histopathology"},{"key":"10.1016\/j.lungcan.2026.109430_b0035","doi-asserted-by":"crossref","first-page":"7571","DOI":"10.21037\/jtd-2019-thym-10","article-title":"Autoimmune disorders and paraneoplastic syndromes in thymoma","volume":"12","author":"Blum","year":"2020","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.lungcan.2026.109430_b0040","doi-asserted-by":"crossref","first-page":"5431","DOI":"10.1007\/s12325-021-01909-1","article-title":"Advances in Treatment of Recurrent Small Cell Lung Cancer (SCLC): Insights for Optimizing Patient Outcomes from an Expert Roundtable Discussion","volume":"38","author":"Das","year":"2021","journal-title":"Adv. Ther."},{"key":"10.1016\/j.lungcan.2026.109430_b0045","doi-asserted-by":"crossref","unstructured":"Cacho-Diaz, B., Salmeron-Moreno, K., Lorenzana-Mendoza, N.A., Texcocano, J., and Arrieta, O. (2018). Myasthenia gravis as a prognostic marker in patients with thymoma. J Thorac Dis 10, 2842-2848. 10.21037\/jtd.2018.04.95.","DOI":"10.21037\/jtd.2018.04.95"},{"key":"10.1016\/j.lungcan.2026.109430_b0050","article-title":"Thymoma in myasthenia gravis: from diagnosis to treatment","volume":"2011","author":"Romi","year":"2011","journal-title":"Autoimmune Dis"},{"key":"10.1016\/j.lungcan.2026.109430_b0055","article-title":"Unraveling molecular networks in thymic epithelial tumors: deciphering the unique signatures","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lungcan.2026.109430_b0060","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1288045","article-title":"Autoimmunity in thymic epithelial tumors: a not yet clarified pathologic paradigm associated with several unmet clinical needs","volume":"15","author":"Perrino","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lungcan.2026.109430_b0065","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1182\/blood.V96.12.3872","article-title":"Thymomas alter the T-cell subset composition in the blood: a potential mechanism for thymoma-associated autoimmune disease","volume":"96","author":"Hoffacker","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.lungcan.2026.109430_b0070","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.bjae.2021.07.001","article-title":"Perioperative management of myasthenia gravis","volume":"21","author":"Daum","year":"2021","journal-title":"BJA Educ"},{"key":"10.1016\/j.lungcan.2026.109430_b0075","article-title":"Long-term prognosis in patients with thymoma combined with myasthenia gravis: a propensity score-matching analysis","volume":"11","author":"Zhao","year":"2024","journal-title":"Front Med (lausanne)"},{"key":"10.1016\/j.lungcan.2026.109430_b0080","article-title":"Advances in biomarkers for immunotherapy in small-cell lung cancer","volume":"15","author":"Li","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lungcan.2026.109430_b0085","doi-asserted-by":"crossref","first-page":"664","DOI":"10.3389\/fimmu.2020.00664","article-title":"Thymoma Associated Myasthenia Gravis (TAMG): Differential Expression of Functional Pathways in Relation to MG Status in Different Thymoma Histotypes","volume":"11","author":"Yamada","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lungcan.2026.109430_b0090","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12974-024-03095-7","article-title":"Thymic gene expression analysis reveals a potential link between HIF-1A and Th17\/Treg imbalance in thymoma associated myasthenia gravis","volume":"21","author":"Altinonder","year":"2024","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.lungcan.2026.109430_b0095","doi-asserted-by":"crossref","first-page":"S137","DOI":"10.1097\/JTO.0000000000000299","article-title":"Alterations of the immune system in thymic malignancies","volume":"9","author":"Weksler","year":"2014","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2026.109430_b0100","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.thorsurg.2018.12.001","article-title":"The Role of the Thymus in the Immune Response","volume":"29","author":"Thapa","year":"2019","journal-title":"Thorac. Surg. Clin."},{"key":"10.1016\/j.lungcan.2026.109430_b0105","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1186\/s12864-022-08880-3","article-title":"Thymic epithelial tumors: examining the GTF2I mutation and developing a novel prognostic signature with LncRNA pairs to predict tumor recurrence","volume":"23","author":"Liu","year":"2022","journal-title":"BMC Genomics"},{"key":"10.1016\/j.lungcan.2026.109430_b0110","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/s42003-022-04002-7","article-title":"Human thymoma-associated mutation of the GTF2I transcription factor impairs thymic epithelial progenitor differentiation in mice","volume":"5","author":"Giorgetti","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.lungcan.2026.109430_b0115","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/imr.12520","article-title":"Tim-3 and its role in regulating anti-tumor immunity","volume":"276","author":"Das","year":"2017","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.lungcan.2026.109430_b0120","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.immuni.2016.05.001","article-title":"Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation","volume":"44","author":"Anderson","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.lungcan.2026.109430_b0125","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1600-065X.2009.00766.x","article-title":"The significance of OX40 and OX40L to T-cell biology and immune disease","volume":"229","author":"Croft","year":"2009","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.lungcan.2026.109430_b0130","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1172\/JCI33976","article-title":"OX40 signaling directly triggers the antitumor effects of NKT cells","volume":"117","author":"Zhou","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lungcan.2026.109430_b0135","article-title":"Analysis of the OX40\/OX40L immunoregulatory axis combined with alternative immune checkpoint molecules in pancreatic ductal adenocarcinoma","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lungcan.2026.109430_b0140","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13045-020-00903-4","article-title":"XPO1-dependent nuclear export as a target for cancer therapy","volume":"13","author":"Azizian","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.lungcan.2026.109430_b0145","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/978-0-387-89520-8_11","article-title":"GITR: a modulator of immune response and inflammation","volume":"647","author":"Nocentini","year":"2009","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.lungcan.2026.109430_b0150","article-title":"New emerging targets in cancer immunotherapy: the role of GITR","volume":"4","author":"Buzzatti","year":"2020","journal-title":"ESMO Open"},{"key":"10.1016\/j.lungcan.2026.109430_b0155","doi-asserted-by":"crossref","unstructured":"Ohm, B., and Jungraithmayr, W. (2022). Balancing the Risk of Adverse Events against the Efficacy of Immunotherapy in Advanced Thymic Epithelial Tumors. Cancers (Basel) 15. 10.3390\/cancers15010289.","DOI":"10.3390\/cancers15010289"},{"key":"10.1016\/j.lungcan.2026.109430_b0160","doi-asserted-by":"crossref","unstructured":"Rajan, A., Sivapiromrat, A.K., and McAdams, M.J. (2024). Immunotherapy for Thymomas and Thymic Carcinomas: Current Status and Future Directions. Cancers (Basel) 16. 10.3390\/cancers16071369.","DOI":"10.3390\/cancers16071369"},{"key":"10.1016\/j.lungcan.2026.109430_b0165","first-page":"e20142","article-title":"Outcomes of immunotherapy in thymoma: a systematic review and meta-analysis","volume":"43","author":"Noor","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2026.109430_b0175","doi-asserted-by":"crossref","first-page":"562","DOI":"10.6004\/jnccn.2013.0072","article-title":"Thymomas and thymic carcinomas: Clinical Practice guidelines in Oncology","volume":"11","author":"Ettinger","year":"2013","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"10.1016\/j.lungcan.2026.109430_b0180","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2796.2011.02427.x","article-title":"The Human Protein Atlas as a proteomic resource for biomarker discovery","volume":"270","author":"Pont\u00e9n","year":"2011","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.lungcan.2026.109430_b0185","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/pro.3307","article-title":"The human protein atlas: a spatial map of the human proteome","volume":"27","author":"Thul","year":"2018","journal-title":"Protein Sci."},{"key":"10.1016\/j.lungcan.2026.109430_b0190","doi-asserted-by":"crossref","unstructured":"Yokoyama, S., and Miyoshi, H. (2018). Thymic tumors and immune checkpoint inhibitors. J Thorac Dis 10, S1509-S1515. 10.21037\/jtd.2017.10.157.","DOI":"10.21037\/jtd.2017.10.157"},{"key":"10.1016\/j.lungcan.2026.109430_b0195","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/JTO.0000000000000429","article-title":"Diffuse high intensity PD-L1 staining in thymic epithelial tumors","volume":"10","author":"Padda","year":"2015","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2026.109430_b0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182665","article-title":"Expression of PD-L1 and other immunotherapeutic targets in thymic epithelial tumors","volume":"12","author":"Arbour","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.lungcan.2026.109430_b0205","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/modpathol.2017.6","article-title":"Expression of PD-1 and PD-L1 in thymic epithelial neoplasms","volume":"30","author":"Weissferdt","year":"2017","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.lungcan.2026.109430_b0210","doi-asserted-by":"crossref","unstructured":"Agrafiotis, A.C., Siozopoulou, V., Hendriks, J.M.H., Pauwels, P., Koljenovic, S., and Van Schil, P.E. (2022). Tumor Microenvironment in Thymic Epithelial Tumors: A Narrative Review. Cancers (Basel) 14. 10.3390\/cancers14246082.","DOI":"10.3390\/cancers14246082"},{"key":"10.1016\/j.lungcan.2026.109430_b0215","doi-asserted-by":"crossref","unstructured":"Stergiou, I.E., Palamaris, K., Levidou, G., Tzimou, M., Papadakos, S.P., Mandrakis, G., Masaoutis, C., Rontogianni, D., and Theocharis, S. (2024). PD-L1 Expression in Neoplastic and Immune Cells of Thymic Epithelial Tumors: Correlations with Disease Characteristics and HDAC Expression. Biomedicines 12. 10.3390\/biomedicines12040772.","DOI":"10.3390\/biomedicines12040772"},{"key":"10.1016\/j.lungcan.2026.109430_b0220","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.lungcan.2017.05.020","article-title":"GTF2I mutation frequently occurs in more indolent thymic epithelial tumors and predicts better prognosis","volume":"110","author":"Feng","year":"2017","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2026.109430_b0225","doi-asserted-by":"crossref","first-page":"e1684","DOI":"10.1002\/ctm2.1684","article-title":"The nuclear export protein exportin-1 in solid malignant tumours: from biology to clinical trials","volume":"14","author":"Lai","year":"2024","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.lungcan.2026.109430_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtocrr.2025.100848","article-title":"Parallel phase II Clinical Trials of Selinexor in patients with Advanced Thymoma and Thymic Carcinoma","author":"Kim","year":"2025","journal-title":"JTO Clinical and Research Reports 6."},{"key":"10.1016\/j.lungcan.2026.109430_b0235","article-title":"Transcriptional landscape of myasthenia gravis revealed by weighted gene coexpression network analysis","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Genet."},{"key":"10.1016\/j.lungcan.2026.109430_b0240","doi-asserted-by":"crossref","unstructured":"Payet, C.A., You, A., Fayet, O.M., Dragin, N., Berrih-Aknin, S., and Le Panse, R. (2022). Myasthenia Gravis: An Acquired Interferonopathy? Cells 11. 10.3390\/cells11071218.","DOI":"10.3390\/cells11071218"},{"key":"10.1016\/j.lungcan.2026.109430_b0245","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1034\/j.1600-0404.2000.102004236.x","article-title":"Expression of OX40 and OX40 ligand (gp34) in the normal and myasthenic thymus","volume":"102","author":"Onodera","year":"2000","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.lungcan.2026.109430_b0250","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/4337399","article-title":"Clinical significance of OX40 and OX40 Ligand in the Peripheral Blood of patients with Myasthenia Gravis","volume":"2022","author":"Zhou","year":"2022","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.lungcan.2026.109430_b0255","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ccell.2018.01.003","article-title":"The Integrated Genomic Landscape of Thymic Epithelial Tumors","volume":"33","author":"Radovich","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.lungcan.2026.109430_b0260","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1097\/JTO.0000000000000298","article-title":"State of the art of genetic alterations in thymic epithelial tumors","volume":"9","author":"Rajan","year":"2014","journal-title":"J. Thorac. Oncol."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500226004915?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500226004915?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T21:43:48Z","timestamp":1783201428000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500226004915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":51,"alternative-id":["S0169500226004915"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2026.109430","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune-related markers define clinically relevant prognostic subgroups in thymic epithelial tumors","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2026.109430","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"109430"}}